AskNiveshClosed·15:59 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to NATCOPHARM

NATCO Pharma Ltd.: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsMar-25Jun-25Sep-25Dec-25Mar-26
Revenue
1,2211,3291,363647739
Other income
66621005878
Segment revenue (incl. inter-segment)
1,2211,3291,363647739
Expenses
781819849544673
Cost of materials consumed
169181175135103
Purchases of stock-in-trade
4137735638
Change in inventories
3915-78-5814
Employee benefit expense
159169200159158
Finance costs
103131011
Depreciation & amortisation
9858524650
Other expenses
264356414196298
EBITDA
615633680217205
EBIT
516575627171155
Operating profit
516575627171155
Profit Before Tax
506572614161144
Tax expense
100929621-89
Deferred tax
-7-24-45-11-105
Net Profit
406480518151269
Financial Ratios
Operating Profit Margin
42.26%43.27%46.00%26.43%20.97%
EBITDA Margin
50.33%47.61%49.85%33.49%27.78%
Net Profit Margin
33.25%36.12%38.00%23.34%36.40%
Earnings Per Share (₹)
22.7026.8428.948.4614.96

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.